Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras suppressor protein 1 (RSU1) is an evolutionarily conserved, leucine-rich repeat (LRR) scaffold protein that participates in key cellular processes such as cell adhesion, migration, survival, growth inhibition, and differentiation[1][4][6][11]. RSU1 is localized at focal adhesions, where it stabilizes the PINCH1–ILK–Parvin complex (“IPP”), regulating integrin signaling and cytoskeletal dynamics[4][5][9]. Originally discovered as a suppressor of Ras-transforming activity, RSU1 modulates Ras-triggered signal transduction, frequently impacting the MAPK and JNK pathways[4]. Its role is complex in cancer, with evidence for both suppression of tumorigenesis and promotion of metastatic behavior, dependent on cellular context and isoform expression[1][2][5]. Alternative splicing of RSU1 yields truncated forms relevant to glioma pathology[1]. Despite its critical cellular role, RSU1 lacks catalytic activity and is being explored as a scaffold/adhesome target in anti-metastatic strategies, especially in liver and breast cancer settings[5]. Direct drug modulators of RSU1 are not known, but its expression and interaction partners may serve as novel biomarker or therapeutic avenues[5][11].
Experimental targeting approaches (anti-metastatic strategies in liver and breast cancer)[5]. Targeting RSU1 expression or RSU1–PINCH1 interaction to modulate cell adhesion and migration[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras suppressor protein 1 (RSU1).